个性化文献订阅>文章检索

文章名     作者     期刊名     摘要     卷     期         如果没有找到您所需要的文献，请点击 ——此处申请     共32条记录   Pharmacological Prevention and Treatment in Clinical At-Risk States for Psychosis [作者：Ruhrmann, S; Klosterkotter, J; Bodatsch, M; Bechdolf, A; Schimmelmann, BG; Nikolaides, A; Hilboll, D; Schultze-Lutter, F,期刊：Current Pharmaceutical Design, 页码：550-557 , 文章类型： Review，,卷期：2012年18-4] Over the last couple of decades, the treatment of psychoses has much advanced; yet, despite all progress, the individual and societal burden associated with psychosis and particularly schizophrenia has largely remained u... Cognitive Behavioral Therapy in Prodromal Psychosis [作者：Addington, J; Marshall, C; French, P,期刊：Current Pharmaceutical Design, 页码：558-565 , 文章类型： Review，,卷期：2012年18-4] There is a strong impetus in the psychosis research field to develop interventions that aim to prevent the onset of psychotic disorders. Over the past 15 years there has been a tremendous development in the work aimed at... Psychoeducation in Subjects at Elevated Risk for Psychosis - A Critical Review [作者：Hauser, M; Juckel, G,期刊：Current Pharmaceutical Design, 页码：566-569 , 文章类型： Review，,卷期：2012年18-4] Pychoeducation is a useful and required intervention in subjects with elevated-risk state of psychosis. Psychoeducation is, however, an under-investigated area in the field of early identification and prevention. Psychoe... Neuroprotective Effects of Low-dose Lithium in Individuals at Ultra-high Risk for Psychosis. A Longitudinal MRI/MRS Study [作者：Berger, GE; Wood, SJ; Ross, M; Hamer, CA; Wellard, RM; Pell, G; Phillips, L; Nelson, B; Amminger, GP; Yung, AR; Jackson, G; Velakoulis, D; Pantelis, C; Manji, H; McGorry, PD,期刊：Current Pharmaceutical Design, 页码：570-575 , 文章类型： Review，,卷期：2012年18-4] Objectives: To investigate if low-dose lithium may counteract the microstructural and metabolic brain changes proposed to occur in individuals at ultra-high risk (UHR) for psychosis.Methods: Hippocampal T2 relaxation tim... Polyunsaturated Fatty Acids in Emerging Psychosis [作者：Mossaheb, N; Schloegelhofer, M; Schaefer, MR; Fusar-Poli, P; Smesny, S; McGorry, P; Berger, G; Amminger, GP,期刊：Current Pharmaceutical Design, 页码：576-591 , 文章类型： Review，,卷期：2012年18-4] The role of polyunsaturated fatty acids and their metabolites for the cause and treatment of psychotic disorders are widely discussed. The efficacy as an augmenting agent in chronic schizophrenia seems to be small or not... Economic Impact of Early Detection and Early Intervention of Psychosis [作者：Valmaggia, LR; McGuire, PK; Fusar-Poli, P; Howes, O; McCrone, P,期刊：Current Pharmaceutical Design, 页码：592-595 , 文章类型： Review，,卷期：2012年18-4] Background: Whilst there is a growing body of evidence relating to the effectiveness of early detection and early intervention services there have been relatively few studies which have provided information on whether th... Philosophical Issues in the Prodromal Phase of Psychosis [作者：Broome, M; Fusar-Poli, P,期刊：Current Pharmaceutical Design, 页码：596-605 , 文章类型： Review，,卷期：2012年18-4] In this paper we try to examine some of the philosophical issues that arise from the clinical and scientific study of the prodromal phase of psychotic illness. These issues can be broadly grouped in to ethical concerns a... Ethical Implications for Clinical Practice and Future Research in "At Risk" Individuals [作者：Singh, F; Mirzakhanian, H; Fusar-Poli, P; de la Fuente-Sandoval, C; Cadenhead, KS,期刊：Current Pharmaceutical Design, 页码：606-612 , 文章类型： Review，,卷期：2012年18-4] The last 15 years have witnessed a shift in schizophrenia research with increasing interest in earlier stages of illness with the hope of early intervention and ultimately prevention of psychotic illness. Large-scale lon... Prodromal Psychosis: Diagnosis and Treatment [作者：Fusar-Poli, P,期刊：Current Pharmaceutical Design, 页码：337-337 , 文章类型： Editorial Material，,卷期：2012年18-4] The Vulnerability to Schizophrenia Mainstream Research Paradigms and Phenomenological Directions [作者：Stanghellini, G; Fusar-Poli, P,期刊：Current Pharmaceutical Design, 页码：338-345 , 文章类型： Review，,卷期：2012年18-4] Early psychopathological attempts to characterize the vulnerability to schizophrenia were based on the phenomenological method. From the beginning, phenomenologically-oriented psychopathologists have searched the basic v... The Ultra High Risk Approach to Define Psychosis Risk [作者：Yung, AR; Fusar-Poli, P; Nelson, B,期刊：Current Pharmaceutical Design, 页码：346-350 , 文章类型： Review，,卷期：2012年18-4] Although prodromal symptoms of psychosis have long been recognized, the clinical management of psychotic disorders conventionally begins at the first episode of frank psychosis, and, until recently, the period immediatel... Basic Symptoms and the Prediction of First-Episode Psychosis [作者：Schultze-Lutter, F; Ruhrmann, S; Fusar-Poli, P; Bechdolf, A; Schimmelmann, BG; Klosterkotter, J,期刊：Current Pharmaceutical Design, 页码：351-357 , 文章类型： Review，,卷期：2012年18-4] Recent focus on early detection and intervention in psychosis has renewed interest in subtle psychopathology beyond positive and negative symptoms. Such self-experienced sub-clinical disturbances are described in detail ... Rationale and First Results of Developing At-Risk (Prodromal) Criteria for Bipolar Disorder [作者：Bechdolf, A; Ratheesh, A; Wood, SJ; Tecic, T; Conus, P; Nelson, B; Cotton, SM; Chanen, AM; Amminger, GP; Ruhrmann, S; Schultze-Lutter, F; Klosterkotter, J; Polij, PF; Yung, AR; Berk, M; McGorry, PD,期刊：Current Pharmaceutical Design, 页码：358-375 , 文章类型： Review，,卷期：2012年18-4] Bipolar affective disorder (BD) is a severe, recurrent and disabling disorder with devastating consequences for individuals, families and society. Although these hazards and costs provide a compelling rationale for devel... Can We Detect Psychotic-like Experiences in the General Population? [作者：Nelson, B; Fusar-Poli, P; Yung, AR,期刊：Current Pharmaceutical Design, 页码：376-385 , 文章类型： Review，,卷期：2012年18-4] The continuum model of psychosis posits that psychotic symptoms are distributed throughout the population, with diagnosable clinical disorder existing at a certain point along this continuum. The total continuum is made ... Reliability and Validity of the Comprehensive Assessment of the at Risk Mental State, Italian Version (CAARMS-I) [作者：Fusar-Poli, P; Hobson, R; Raduelli, M; Balottin, U,期刊：Current Pharmaceutical Design, 页码：386-391 , 文章类型： Review，,卷期：2012年18-4] The Comprehensive Assessment of the At Risk Mental State (CAARMS) is a semi-structured interview designed to assess attenuated psychotic symptoms in people at ultra high risk of developing psychosis (UHR). It is widely u... Abnormal Bodily Experiences May be a Marker of Early Schizophrenia? [作者：Stanghellini, G; Ballerini, M; Poli, PF; Cutting, J,期刊：Current Pharmaceutical Design, 页码：392-398 , 文章类型： Review，,卷期：2012年18-4] The purpose of this study is to answer the following question: What are the typical features of abnormal bodily experiences (ABEs) in persons affected by acute first-episode schizophrenia? Our overall objective is to con...